{
    "Trade/Device Name(s)": [
        "HemosIL AcuStar Anti-\u03b22 Glycoprotein-I IgG",
        "HemosIL AcuStar Anti-\u03b22 Glycoprotein-I IgM",
        "HemosIL AcuStar Anti-\u03b22 Glycoprotein-I IgG Controls",
        "HemosIL AcuStar Anti-\u03b22 Glycoprotein-I IgM Controls"
    ],
    "Submitter Information": "Instrumentation Laboratory Co.",
    "510(k) Number": "k091556",
    "Predicate Device Reference 510(k) Number(s)": [
        "K031208"
    ],
    "Regulatory Class": "Class II (Assays); Class I (Controls)",
    "Product Code(s)": [
        "MSV",
        "JJX"
    ],
    "Summary Letter Date": "May 14, 2010",
    "Summary Letter Received Date": "May 17, 2010",
    "Submission Date": "March 3, 2010",
    "Regulation Number(s)": [
        "21 CFR 866.5660",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Multiple autoantibodies immunological test system",
        "Single (specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "immunology",
        "autoimmune"
    ],
    "Analyte(s)": [
        "Anti-\u03b22 Glycoprotein-I IgG",
        "Anti-\u03b22 Glycoprotein-I IgM"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Citrated Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ACL AcuStar"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay"
    ],
    "Methodologies": [
        "Two-step immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for HemosIL AcuStar Anti-\u03b22 Glycoprotein-I IgG and IgM chemiluminescent immunoassays and associated controls for use on ACL AcuStar analyzer.",
    "Indications for Use Summary": "Semi-quantitative measurement of anti-\u03b22 Glycoprotein-I IgG and IgM antibodies in human citrated plasma and serum to aid in diagnosis of thrombotic disorders related to primary and secondary Antiphospholipid Syndrome (APS), used with ACL AcuStar; controls for assay quality control.",
    "fda_folder": "Immunology"
}